BIIB vs NVO
Biogen Inc. · Novo Nordisk A/S
Relative return (rebased to 100)
Key stats
| Metric | BIIB | NVO |
|---|---|---|
| Price | $225.36 | $39.40 |
| Market Cap | $33.27B | $175.09B |
| P/E | 25.73 | — |
| P/B | 1.78 | — |
| P/S | 3.36 | — |
| ROE | 6.9% | — |
| Net Margin | 13.1% | — |
| Gross Margin | 117.7% | — |
| Revenue Growth | 2.2% | — |
| Dividend Yield | — | — |
| EPS | $8.76 | — |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.